Abbvie Inc Stock In The News

ABBV Stock  USD 178.49  0.61  0.34%   
The overall news coverage of AbbVie Inc from major news outlets shows bullish sentiment on 62 news articles, blog posts, and TV commentaries analyzed in the last few months. Our overall analysis of AbbVie's news coverage and content from conventional and social sources shows investors' bearish mood towards AbbVie Inc. The specific impact of AbbVie news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of AbbVie's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using AbbVie headlines in addition to utilizing other, more conventional financial analysis modules. Check out AbbVie Backtesting and AbbVie Hype Analysis.

AbbVie Today Top News and Investor Outlook

Yahoo News
2 Top Dividend Stocks to Buy Hand Over Fist
https://finance.yahoo.com/news/2-top-dividend-stocks-buy-121500289.html
 Bullish
Yahoo News
Neurocrine Biosciences Is Pioneering Therapies for Neurological Disorders
https://finance.yahoo.com/news/neurocrine-biosciences-pioneering-therapies-neurological-140001407.html
 Bullish
Yahoo News
11 Oversold Healthcare Stocks To Buy Right Now
https://finance.yahoo.com/news/11-oversold-healthcare-stocks-buy-121714179.html
 Bullish
sbwire news
SCHD ETF Spotlight: The Top 6 Stocks Inside This Dividend Monster
https://investorplace.com/2024/03/schd-etf-spotlight-the-top-6-stocks-inside-this-dividend-monster/
 Bullish
Yahoo News
15 Best States To Live In: 2024 Rankings
https://finance.yahoo.com/news/15-best-states-live-2024-172028729.html
 Bullish
Yahoo News
13 Dividend Kings To Invest In For Safe Dividend Growth
https://finance.yahoo.com/news/13-dividend-kings-invest-safe-123302554.html
 Bullish
sbwire news
3 Must-Have Dividend Kings for a Steady Income Stream
https://investorplace.com/2024/03/3-must-have-dividend-kings-for-a-steady-income-stream/
 Neutral
sbwire news
Trouble-Proof Dividend Darlings: 7 Stocks That Keep Paying No Matter What
https://investorplace.com/2024/03/trouble-proof-dividend-darlings-7-stocks-that-keep-paying-no-matter-what/
 Bullish
sbwire news
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
https://investorplace.com/2024/03/3-unstoppable-mega-cap-stocks-that-every-investor-should-own-in-2024/
 Bearish
Yahoo News
AbbVie (ABBV) Stock Slides as Market Rises: Facts to Know Before You Trade
https://finance.yahoo.com/news/abbvie-abbv-stock-slides-market-224520245.html
 Bullish

AbbVie Inc Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide AbbVie and other traded companies coverage. We help investors stay connected with AbbVie headlines for the 19th of March to make an informed investment decision based on correlating the impacts of news items on AbbVie Stock performance. Please note that trading solely based on the AbbVie Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
AbbVie's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help AbbVie Inc investors visualize upcoming and past events in order to time the market based on AbbVie Inc noise-free hype analysis.
AbbVie stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the AbbVie earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about AbbVie that are available to investors today. That information is available publicly through AbbVie media outlets and privately through word of mouth or via AbbVie internal channels. However, regardless of the origin, that massive amount of AbbVie data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AbbVie news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AbbVie relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AbbVie's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AbbVie alpha.

AbbVie Largest EPS Surprises

Earnings surprises can significantly impact AbbVie's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-04-23
2015-03-310.850.940.0910 
2014-10-31
2014-09-300.770.890.1215 
View All Earnings Estimates

AbbVie Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to AbbVie Inc Stock. Current markets are slightly bullish. About 53% of major world exchanges and indexes are currently up. See today's market update for more information.
cnbc News
18th of March 2024
Jefferies likes these dividend-growing stocks for 2024
at cnbc.com 
Yahoo News
15th of March 2024
Global Aesthetic Injectables Market by Type , Application , End User - Forecast 2024-2030
at finance.yahoo.com 
Yahoo News
13th of March 2024
Hormonal Contraceptive Market is Set to Achieve Staggering USD 33.8 billion Valuation by 2...
at finance.yahoo.com 
news
12th of March 2024
AbbVie Inc. Shares Bought by EP Wealth Advisors LLC
at thelincolnianonline.com 
news
11th of March 2024
AbbVie Inc. Shares Sold by Connors Investor Services Inc.
at thelincolnianonline.com 
news
6th of March 2024
AbbVie Hits New 12-Month High at 179.98
at thelincolnianonline.com 
news
4th of March 2024
AbbVie Inc. Shares Sold by Legal General Group Plc
at thelincolnianonline.com 
zacks News
29th of February 2024
Disposition of 3387 shares by Perry Siatis of AbbVie at 178.04 subject to Rule 16b-3
at zacks.com 

AbbVie Investors Sentiment

The influence of AbbVie's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in AbbVie. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to AbbVie's public news can be used to forecast risks associated with an investment in AbbVie. The trend in average sentiment can be used to explain how an investor holding AbbVie can time the market purely based on public headlines and social activities around AbbVie Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
AbbVie's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for AbbVie's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average AbbVie's news discussions. The higher the estimated score, the more favorable is the investor's outlook on AbbVie.

AbbVie Implied Volatility

    
  23.22  
AbbVie's implied volatility exposes the market's sentiment of AbbVie Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if AbbVie's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that AbbVie stock will not fluctuate a lot when AbbVie's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AbbVie in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AbbVie's short interest history, or implied volatility extrapolated from AbbVie options trading.
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out AbbVie Backtesting and AbbVie Hype Analysis.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.